Morgan Stanley analyst Megan Alexander Clapp raised the firm’s price target on Vital Farms (VITL) to $48 from $41 and keeps an Overweight rating on the shares. A Q2 beat and guidance raise “underscore accelerating growth momentum,” the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms price target raised to $50 from $44 at BMO Capital
- Vital Farms: Strong Market Performance and Strategic Growth Drive Buy Rating
- Vital Farms Reports Strong Q2 2025 Growth
- Vital Farms’ Strong Q2 Performance and Raised 2025 Guidance Justify Buy Rating
- Vital Farms reports Q2 EPS 36c, consensus 27c